(Q31136626)

29 June 2017

title

Novel bright field molecular morphology methods for detection of HER2 gene amplification (English)

1 reference

29 June 2017

Raymond Tubbs

1

1 reference

29 June 2017

James Pettay

2

1 reference

29 June 2017

David Hicks

3

1 reference

29 June 2017

Marek Skacel

4

1 reference

29 June 2017

Richard Powell

5

1 reference

29 June 2017

Tom Grogan

6

1 reference

29 June 2017

James Hainfeld

7

1 reference

29 June 2017

publication date

1 August 2004

1 reference

Journal of Molecular Histology

29 June 2017

published in

1 reference

29 June 2017

volume

35

1 reference

29 June 2017

issue

6

1 reference

29 June 2017

page(s)

589-594

1 reference

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

29 June 2017

cites work

1 reference

12 December 2020

Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression

1 reference

12 December 2020

Sensitive in situ hybridization with catalyzed reporter deposition, streptavidin-Nanogold, and silver acetate autometallography: detection of single-copy human papillomavirus

1 reference

12 December 2020

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

1 reference

12 December 2020

New frontiers in gold labeling

1 reference

12 December 2020

Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.

1 reference

12 December 2020

Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples.

1 reference

12 December 2020

Emerging technologies for HER2 testing.

1 reference

12 December 2020

Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message

1 reference

12 December 2020

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

1 reference

12 December 2020

Her-2/neu oncogene amplification and protein over-expression in interval and screen-detected breast cancers

1 reference

12 December 2020

The combination of in situ hybridization and immunohistochemical analysis: an evaluation of Her2/neu expression in paraffin-embedded breast carcinomas and adjacent normal-appearing breast epithelium

1 reference

12 December 2020

Chromogenic in situ hybridization: a novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma

1 reference

12 December 2020

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

1 reference

12 December 2020

Interobserver interpretative reproducibility of GOLDFISH, a first generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma.

1 reference

12 December 2020

Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma

1 reference

12 December 2020

Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer.

1 reference

12 December 2020

Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray.

1 reference

12 December 2020

Gold-facilitated in situ hybridization: a bright-field autometallographic alternative to fluorescence in situ hybridization for detection of Her-2/neu gene amplification

1 reference

12 December 2020

Chromogenic in situ hybridization analysis of HER-2/neu status in breast carcinoma: application in screening of patients for trastuzumab (Herceptin) therapy

1 reference

12 December 2020

Expression of C-KIT and HER-2 tyrosine kinase receptors in poor-prognosis breast cancer

1 reference

12 December 2020

Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer

1 reference

12 December 2020

Clinical laboratory assays for HER-2/neu amplification and overexpression: quality assurance, standardization, and proficiency testing

1 reference

12 December 2020

Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis.

1 reference

12 December 2020

Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer

1 reference

12 December 2020

Quantitative Assessment of HER-2/Neu Protein Concentration in Breast Cancer by Enzyme-Linked Immunosorbent Assay

1 reference

12 December 2020

The quality of Her-2/Neu predictive immunohistochemistry: something FISHy?

1 reference

12 December 2020

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

12 December 2020

Metastatic breast cancer of HER2 scored 2+ by IHC and HER2 gene amplification assayed by FISH has a good response to single agent therapy with trastuzumab: A case report

1 reference

12 December 2020

HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization

1 reference

12 December 2020

Introduction of a novel HRP substrate-Nanogold probe for signal amplification in immunocytochemistry

1 reference

12 December 2020

10.1007/S10735-004-2191-9

Identifiers

DOI

1 reference

29 June 2017

1 reference